Dear Doctor Letter (Rote-Hand-Brief) on TYGACIL® (tigecycline): Restrictions in all indications
2011.03.17
Active substance: tigecycline
Important information on restrictions in all indications of TYGACIL® (tigecycline) due to increased mortality observed in clinical trials.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN